4.7(top 5%)
impact factor
1.5K(top 20%)
papers
28.8K(top 10%)
citations
66(top 10%)
h-index
4.8(top 10%)
impact factor
2.0K
all documents
32.6K
doc citations
98(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass ItACS Infectious Diseases2015442
2Quaternary Ammonium Compounds: An Antimicrobial Mainstay and Platform for Innovation to Address Bacterial ResistanceACS Infectious Diseases2015441
3Therapeutic Potential of Spirooxindoles as Antiviral AgentsACS Infectious Diseases2016350
4Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human PrimatesACS Infectious Diseases2016265
5Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic PotentialACS Infectious Diseases2020252
6Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like ProteaseACS Infectious Diseases2020239
7Evaluation of Ebola Virus Inhibitors for Drug RepurposingACS Infectious Diseases2015209
8Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 PatientsACS Infectious Diseases2020200
9Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin PeptidesACS Infectious Diseases2016191
10Developments in Glycopeptide AntibioticsACS Infectious Diseases2018185
11Helping Chemists Discover New AntibioticsACS Infectious Diseases2015176
12The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?ACS Infectious Diseases2017166
13A Comparison of Optical, Electrochemical, Magnetic, and Colorimetric Point-of-Care Biosensors for Infectious Disease DiagnosisACS Infectious Diseases2018154
14New Perspectives in Biofilm EradicationACS Infectious Diseases2018147
15A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IVACS Infectious Diseases2015140
16Synergistic Photothermal and Antibiotic Killing of Biofilm-Associated Staphylococcus aureus Using Targeted Antibiotic-Loaded Gold NanoconstructsACS Infectious Diseases2016139
17Rational Design of Single-Chain Polymeric Nanoparticles That Kill Planktonic and Biofilm BacteriaACS Infectious Diseases2017134
18Surface-Enhanced Raman Spectroscopy-Based Sandwich Immunoassays for Multiplexed Detection of Zika and Dengue Viral BiomarkersACS Infectious Diseases2017134
19Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-Line Antibiotics against Multidrug-Resistant Gram-Negative BacteriaACS Infectious Diseases2015124
20Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor DesignACS Infectious Diseases2019123
21Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond FurinACS Infectious Diseases2021122
22Solving the Antibiotic CrisisACS Infectious Diseases2015119
23Zika Virus Genomic RNA Possesses Conserved G-Quadruplexes Characteristic of the Flaviviridae FamilyACS Infectious Diseases2016117
24Getting Drugs into Gram-Negative Bacteria: Rational Rules for Permeation through General PorinsACS Infectious Diseases2018117
25Anti-SARS-CoV-2 Potential of Artemisinins In VitroACS Infectious Diseases2020117
26Current and Perspective Diagnostic Techniques for COVID-19ACS Infectious Diseases2020116
27Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ MiceACS Infectious Diseases2016111
28Nanomaterials for the Treatment of Bacterial BiofilmsACS Infectious Diseases2016111
29Comparative Analysis of Primer–Probe Sets for RT-qPCR of COVID-19 Causative Virus (SARS-CoV-2)ACS Infectious Diseases2020111
30Prediction of Drug Penetration in Tuberculosis LesionsACS Infectious Diseases2016110
31Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B StreptococcusACS Infectious Diseases2017110
32Recent Innovations in Bacterial Infection Detection and TreatmentACS Infectious Diseases2021106
33Potassium Iodide Potentiates Broad-Spectrum Antimicrobial Photodynamic Inactivation Using PhotofrinACS Infectious Diseases2017105
34Multitarget Approaches against Multiresistant SuperbugsACS Infectious Diseases2020103
35Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 CarbapenemaseACS Infectious Diseases2015100
36Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus GyraseACS Infectious Diseases201999
37Exhaled Volatile Organic Compounds of Infection: A Systematic ReviewACS Infectious Diseases201796
38Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2?ACS Infectious Diseases202096
39Bicarbonate Alters Bacterial Susceptibility to Antibiotics by Targeting the Proton Motive ForceACS Infectious Diseases201892
40Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell DependenciesACS Infectious Diseases202092
41Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying EnzymesACS Infectious Diseases201891
42Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux PumpACS Infectious Diseases201788
43Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47ACS Infectious Diseases201887
44Kill the Real with the Fake: Eliminate Intracellular Staphylococcus aureus Using Nanoparticle Coated with Its Extracellular Vesicle Membrane as Active-Targeting Drug CarrierACS Infectious Diseases201987
45Structure–Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosisACS Infectious Diseases201686
46Liposomes for Antibiotic Encapsulation and DeliveryACS Infectious Diseases202086
47High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent MalariaACS Infectious Diseases201684
48Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor SynthesisACS Infectious Diseases201683
49Slippery Liquid-Infused Porous Surfaces that Prevent Bacterial Surface Fouling and Inhibit Virulence Phenotypes in Surrounding Planktonic CellsACS Infectious Diseases201683
50The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for TuberculosisACS Infectious Diseases201783